Step 1 topics → Renal → Renal Cell Carcinoma

Renal Cell Carcinoma

USMLE Step 1 trap: Misidentifies the cell of origin of clear cell RCC as collecting duct rather than proximal tubule. Clear cell RCC, the most common subtype, arises from proximal tubular epithelium.

Renal cell carcinoma is one of those topics where USMLE Step 1 will hit you from multiple angles in a single vignette. You need to know the classic triad (hematuria, flank pain, palpable mass), recognize that smoking is the dominant risk factor, and immediately identify clear cell as the most common subtype — arising from proximal tubular epithelium, not collecting duct. The exam loves to embed RCC in a scenario where the diagnosis is hidden behind a paraneoplastic syndrome or an unexpected finding like a left-sided varicocele, forcing you to work backwards to the primary tumor.

The paraneoplastic angle is heavily tested. RCC can ectopically secrete EPO (polycythemia), PTHrP (hypercalcemia), or renin (hypertension). Students who memorize 'cancer causes anemia' get burned here — polycythemia is the classic paraneoplastic finding the exam wants. Hypercalcemia from PTHrP is equally high-yield. If a vignette describes a middle-aged smoker with elevated hematocrit or hypercalcemia and no obvious bone mets, think RCC.

VHL disease and the molecular mechanism behind sporadic clear cell RCC show up as application questions on USMLE Step 1, not just recall. You need to understand that VHL is a tumor suppressor — its loss stabilizes HIF-1α, which drives VEGF and PDGF upregulation and promotes angiogenesis. Students who think of VHL as an oncogene will get the mechanism questions wrong. The IVC extension / left varicocele presentation is a classic 'connector' fact the exam uses to see if you understand how the tumor spreads beyond the kidney.

From real student decks
78%have cards covering this topic
57%have mature cards
2median lapses in 14 days

Common misconceptions

Common mistake
Wrong: RCC arises from the renal collecting ducts.
Right: Clear cell RCC, the most common subtype, arises from proximal tubular epithelium.
Clear cell RCC — the most common subtype, accounting for roughly 70–75% of RCC — originates from the epithelium of the proximal convoluted tubule, not the collecting duct. Collecting duct carcinoma is a rare, aggressive variant that's a separate entity entirely. Getting the cell of origin right matters because it connects to the VHL/HIF-1α pathway, which is specific to proximal tubule-derived tumors.
Common mistake
Wrong: RCC most commonly causes anemia as its paraneoplastic effect.
Right: RCC can ectopically secrete EPO causing polycythemia, PTHrP causing hypercalcemia, and renin causing hypertension — polycythemia and hypercalcemia are the classic paraneoplastic findings.
The 'all cancers cause anemia' heuristic will fail you here. RCC ectopically secretes EPO, which drives excess red cell production — resulting in polycythemia, not anemia. Similarly, PTHrP secretion causes hypercalcemia independent of bone metastases. When a vignette shows elevated hematocrit or unexplained hypercalcemia alongside a renal mass or hematuria, polycythemia and hypercalcemia are the paraneoplastic findings to invoke, not anemia.
Common mistake
Wrong: VHL mutation causes RCC by directly activating an oncogene.
Right: VHL is a tumor suppressor; its loss prevents HIF-1α degradation, leading to constitutive upregulation of VEGF and PDGF, driving angiogenesis and tumor growth.
VHL is unambiguously a tumor suppressor gene — it follows the two-hit model. The VHL protein normally targets HIF-1α for ubiquitin-mediated proteasomal degradation under normoxic conditions. When both VHL alleles are lost, HIF-1α accumulates constitutively, acting as a transcription factor that upregulates VEGF, PDGF, and other pro-angiogenic genes. This is a loss-of-function mechanism, not oncogene activation.
Common mistake
Gap: Misses that RCC invades the renal vein/IVC and can present with a left varicocele that does not decompress supine
RCC characteristically extends into the renal vein and inferior vena cava as a tumor thrombus, which can cause a left-sided varicocele when the left renal vein is obstructed.
RCC has a well-known propensity to grow as a tumor thrombus directly into the renal vein and extend up the inferior vena cava. When the left renal vein is obstructed, venous drainage of the left testicle (which empties into the left renal vein) is impaired, causing a left-sided varicocele. The key clinical clue: this varicocele does NOT decompress when the patient lies supine, distinguishing it from a benign varicocele. A new left varicocele in an older man should prompt imaging for RCC.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the classic triad of RCC (flank pain, hematuria, palpable abdominal mass), identify smoking as the primary modifiable risk factor, and recognize clear cell carcinoma as the most common subtype arising from proximal tubular epithelium.
  2. Identify the paraneoplastic syndromes associated with RCC: ectopic EPO causing polycythemia, PTHrP causing hypercalcemia, and renin causing secondary hypertension — and distinguish these from the anemia of chronic disease.
  3. Explain VHL as a tumor suppressor gene whose biallelic loss (germline in VHL disease, somatic in sporadic cases) prevents HIF-1α degradation, constitutively upregulating VEGF and PDGF to drive tumor angiogenesis.

Can you avoid these mistakes?

A 58-year-old male smoker presents with gross hematuria, left flank pain, and lab work showing a hematocrit of 58%. Imaging reveals a solid renal mass. What is the most likely diagnosis, what paraneoplastic mechanism explains the elevated hematocrit, and from what cell type does the most common subtype of this tumor arise?
A patient with VHL disease is found to have a bilateral renal mass on screening MRI. You explain that the VHL gene mutation predisposes to this tumor. A classmate says 'VHL is an oncogene that gets activated.' How do you correct this, and what downstream pathway does VHL loss affect?
A 62-year-old man presents with a new left-sided varicocele that his urologist notes does not disappear when he lies flat. What underlying diagnosis should be at the top of your differential, and what anatomical mechanism explains this finding?
A vignette describes a patient with a renal mass, no bone metastases on imaging, and a serum calcium of 12.8 mg/dL. What is the paraneoplastic mechanism of hypercalcemia in RCC, and how does this differ from hypercalcemia due to bony metastases?

Related topics

Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →